Homozygous SCN1B/β1 pathogenic variants have been later identified in DEE patients that were initially included in the Dravet syndrome spectrum (Patino et al., 2009). Here, SCN1B is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.